These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21681752)

  • 21. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
    Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method.
    Kushida I; Gotoda M
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The improved dissolution performance of a post processing treated spray-dried crystalline solid dispersion of poorly soluble drugs.
    Chan SY; Toh SM; Khan NH; Chung YY; Cheah XZ
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1800-12. PubMed ID: 27049232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raman mapping for kinetic analysis of crystallization of amorphous drug based on distributional images.
    Ueda H; Ida Y; Kadota K; Tozuka Y
    Int J Pharm; 2014 Feb; 462(1-2):115-22. PubMed ID: 24368105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling Physical Stability of Amorphous Solids Based on Temperature and Moisture Stresses.
    Zhu DA; Zografi G; Gao P; Gong Y; Zhang GGZ
    J Pharm Sci; 2016 Sep; 105(9):2932-2939. PubMed ID: 27185539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage.
    Edueng K; Mahlin D; Gråsjö J; Nylander O; Thakrani M; Bergström CAS
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31357587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystalline phase transition of ezetimibe in final product, after packing, promoted by the humidity of excipients: Monitoring and quantification by Raman spectroscopy.
    Farias MADS; Soares FLF; Carneiro RL
    J Pharm Biomed Anal; 2016 Mar; 121():209-214. PubMed ID: 26812479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy.
    Okumura T; Otsuka M
    Pharm Res; 2005 Aug; 22(8):1350-7. PubMed ID: 16078145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NMR.
    Ito A; Watanabe T; Yada S; Hamaura T; Nakagami H; Higashi K; Moribe K; Yamamoto K
    Int J Pharm; 2010 Jan; 383(1-2):18-23. PubMed ID: 19732816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
    Paudel A; Loyson Y; Van den Mooter G
    J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2011 Jun; 100(6):2460-8. PubMed ID: 21246560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
    Naelapää K; Boetker JP; Veski P; Rantanen J; Rades T; Kogermann K
    Int J Pharm; 2012 Jun; 429(1-2):69-77. PubMed ID: 22433471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
    Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
    Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine.
    Baghel S; Cathcart H; Redington W; O'Reilly NJ
    Eur J Pharm Biopharm; 2016 Jul; 104():59-71. PubMed ID: 27108783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screen for Inhibitors of Crystal Growth to Identify Desirable Carriers for Amorphous Solid Dispersions Containing Felodipine.
    Fu J; Cui L; Yang C; Xiong H; Ren G; Ma X; Jing Q; Ren F
    AAPS PharmSciTech; 2018 Apr; 19(3):1231-1242. PubMed ID: 29302871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Devitrification of amorphous celecoxib.
    Gupta P; Bansal AK
    AAPS PharmSciTech; 2005 Sep; 6(2):E223-30. PubMed ID: 16353981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.